Background: There are limited data on primary human immunodeficiency virus drug resistance (HIVDR) in pediatric populations. This study aimed to assess the prevalence of primary HIVDR and associated risk factors among children initiating first-line antiretroviral therapy (ART) in Uganda.
Methods: At three Ugandan clinics, children (age <12 years) requiring ART were recruited between January 2010 and August 2011.